Metabolic dysfunction associated fatty liver disease (MAFLD), metabolic dysfunction associated steatotic liver disease (MASLD), metabolic associated steatohepatitis (MASH) and obesity

Best Practice & Research Clinical Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles